Pharma News
Looking out for latest news on Pharma Magazine?
Check out the latest Pharma news, Top news in Pharma Magazine, Leading Magazine in Pharma industry. Daily news updates pertinent to the industrial sectors we are engaged with are depicted on the news section of Pharma industry which we operate.
Vesselon Acquires FDA-Approved Lipid Microsphere Drug Imagent® For Therapeutic Platform
Thursday, August 08, 2019Vesselon an oncology therapeutics company today announced the acquisition of an FDAapproved drug Imagent Vesselon will use Imagent to create novel therapeutic complexes in four classes of cancer drugs cytokines oncolytic viruses monoclonal antibodies...
Caladrius Biosciences and Cognate BioServices Establish Manufacturing Agreement for Phase 3 Confirmatory Pivotal Clinical Trial of CLBS14
Thursday, August 08, 2019Caladrius Biosciences Inc a latestage therapeutics development biopharmaceutical company pioneering advancements of cell therapies in select cardiovascular and autoimmune diseases and Cognate BioServices Inc Cognate a leading contract development and...
ADC Therapeutics and SOPHiA GENETICS Partner for Biomarker Discovery in Pivotal Phase II Clinical Trial
Wednesday, August 07, 2019ADC Therapeutics an oncology drug discovery and development company that specializes in the development of antibody drug conjugates ADCs and SOPHiA GENETICS a leader in DataDriven Medicine today announced they have entered into a collaboration to ide...
Aquinox Pharmaceuticals and Neoleukin Therapeutics announce merger agreement
Wednesday, August 07, 2019Aquinox Pharmaceuticals Inc and Neoleukin Therapeutics Inc Neoleukin a privately held biopharmaceutical company utilizing sophisticated computational methods to design de novo protein therapeutics today announced that the two companies entered into a...
Neuropore Therapies and BenevolentAI Enter Strategic Collaboration to Discover Novel Therapeutics Through the Application of Artificial Intelligence
Tuesday, August 06, 2019Neuropore Therapies Inc announced today that it entered into a collaboration with BenevolentAI to evaluate molecular targets implicated in progressive degenerative diseases which were identified through artificial intelligence The molecular targets o...
Innovent and Shenogen Announce Collaboration to Evaluate Tyvyt® (Sintilimab injection) in Combination with SNG1005 for the Treatment of Patients with Advanced Cancer
Tuesday, August 06, 2019Innovent Biologics Inc a worldclass biopharmaceutical company that develops and commercializes high quality medicines today announced the signing of a collaboration agreement with Shenogen Pharma Group Ltd Shenogen to evaluate the combination therapy...
Telix Pharmaceuticals and German Cancer Research Center (DKFZ) Enter into Collaboration and Option Agreement for Image-Guided Prostate Surgery
Monday, August 05, 2019Telix Pharmaceuticals Limited a clinicalstage biopharmaceutical company focused on the development of diagnostic and therapeutic products based on targeted radiopharmaceuticals or molecularlytargeted radiation MTR has today announced that it has ente...
Harrow Health Forms Stowe Pharmaceuticals Subsidiary to Develop Broad Spectrum Anti-Microbial Ophthalmic and Otic Therapeutics
Saturday, August 03, 2019Harrow Health Inc today announced that its newly formed subsidiary Stowe Pharmaceuticals Inc has entered into an agreement with TGV Health to acquire worldwide rights to the Zian antimicrobial molecule for ophthalmic and otic uses Zian is a patented...
Can-Fite Signs Agreement with Kyongbo Pharm for the Distribution in South Korea of Piclidenoson in the Treatment of Psoriasis
Friday, August 02, 2019CanFite BioPharma Ltd a biotechnology company advancing a pipeline of proprietary small molecule drugs that address cancer liver and inflammatory diseases today announced it has signed a distribution agreement with Kyongbo Pharm Co Ltd to distribute...
Rafael Pharmaceuticals Announces Expansion into Austria, South Korea and Spain of Pivotal Phase 3 Trial of CPI-613 in Patients
Friday, August 02, 2019Rafael Pharmaceuticals Inc a leader in the growing field of cancer metabolismbased therapeutics today announced the expansion of its Phase clinical trial ARMADA of CPI devimistat in patients with relapsed or refractory acute myeloid leukemia AML in...
